HYPOCHONDROPLASIA
Clinical trials for HYPOCHONDROPLASIA explained in plain language.
Never miss a new study
Get alerted when new HYPOCHONDROPLASIA trials appear
Sign up with your email to follow new studies for HYPOCHONDROPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for babies with rare growth disorder
Disease control Recruiting nowThis study is testing whether a daily injection called vosoritide can safely help infants and young children with hypochondroplasia grow better. It will involve about 60 children under 3 years old, who will receive either the drug or a placebo for one year. The main goals are to …
Matched conditions: HYPOCHONDROPLASIA
Phase: PHASE2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Wearable tech tracks daily movement in rare growth condition
Knowledge-focused Recruiting nowThis study aims to test how well a wearable sensor device, called Syde®, can reliably measure limb movements in people with achondroplasia or hypochondroplasia. About 40 participants aged 3 and older will wear the device at home over a year to collect movement data. The goal is t…
Matched conditions: HYPOCHONDROPLASIA
Sponsor: SYSNAV • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists track rare growth disorder in kids to understand its natural course
Knowledge-focused Recruiting nowThis study aims to better understand hypochondroplasia, a rare genetic condition that causes short stature, by observing children over time. Researchers will track growth, health complications, quality of life, and physical abilities in 150 children aged 2.5 to 17. No treatment o…
Matched conditions: HYPOCHONDROPLASIA
Sponsor: QED Therapeutics, a BridgeBio company • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC